1-4 of 4
proto-oncogene proteins c-rel
Close
Sort by
Journal Articles

Targeted Therapy of B Cell Lymphoma with a Direct Inhibitor of the NF-κB Subunit c-Rel

Yusuke Shono, MD PhD, Andrea Z. Tuckett, PhD, Hsiou-Chi Liou, PhD, Samedy Ouk, PhD, Ekaterina Doubrovina, MD PhD, Mikhail Doubrovin, MD PhD, Enrico Derenzini, MD, Mary I. Scallion, BS, Jennifer J. Tsai, MD, Odette M. Smith, Anas Younes, MD PhD, Richard J. O'Reilly, MD PhD, Marcel R.M. van den Brink, MD PhD, Johannes L. Zakrzewski, MD
Journal: Blood
Blood (2014) 124 (21): 507.
https://doi.org/10.1182/blood.V124.21.507.507
Published: 2014
Journal Articles

MiR-181a Is a Master Regulator of the Nuclear Factor-κB Signaling Pathway in Diffuse Large B Cell Lymphoma

Goldi A. Kozloski, PhD, Xiaoyu Jiang, PhD, Karen L. Bunting, PhD, Ari M. Melnick, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2012) 120 (21): 417.
https://doi.org/10.1182/blood.V120.21.417.417
Published: 2012
Journal Articles

c-Rel plays a key role in deficient activation of B cells from a non–X-linked hyper-IgM patient

Clinical Trials & Observations
Kristina T. Lu, Frank L. Sinquett, Rebecca L. Dryer, Charles Song, Lori R. Covey
Journal: Blood
Blood (2006) 108 (12): 3769–3776.
https://doi.org/10.1182/blood-2006-03-008839
Published: 2006
Journal Articles

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma

Thomas F. E. Barth, José I. Martin-Subero, Stefan Joos, Christiane K. Menz, Cornelia Hasel, Gunhild Mechtersheimer, Reza M. Parwaresch, Peter Lichter, Reiner Siebert, Peter Möller
Journal: Blood
Blood (2003) 101 (9): 3681–3686.
https://doi.org/10.1182/blood-2002-08-2577
Published: 2003